HUT35690A - Process for preparing ganglioside derivatives and pharmaceutical compositions containing such compounds as active substances - Google Patents

Process for preparing ganglioside derivatives and pharmaceutical compositions containing such compounds as active substances

Info

Publication number
HUT35690A
HUT35690A HU842819A HU281984A HUT35690A HU T35690 A HUT35690 A HU T35690A HU 842819 A HU842819 A HU 842819A HU 281984 A HU281984 A HU 281984A HU T35690 A HUT35690 A HU T35690A
Authority
HU
Hungary
Prior art keywords
ganglioside
sub
compounds
pharmaceutical compositions
compositions containing
Prior art date
Application number
HU842819A
Other languages
English (en)
Other versions
HU198091B (en
Inventor
Ezio Tubaro
Giovanni Cavallo
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of HUT35690A publication Critical patent/HUT35690A/hu
Publication of HU198091B publication Critical patent/HU198091B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
HU842819A 1983-07-21 1984-07-20 Process for producing ganglioside derivatives and pharmaceutical compositions comprising same as active ingedient HU198091B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48724/83A IT1168205B (it) 1983-07-21 1983-07-21 Derivato di monsialo ganglioside dotato di attivita' antibatterica, antifungina ed antitumorale, composizioni che lo contengono e procedimento per la loro preparazione

Publications (2)

Publication Number Publication Date
HUT35690A true HUT35690A (en) 1985-07-29
HU198091B HU198091B (en) 1989-07-28

Family

ID=11268264

Family Applications (1)

Application Number Title Priority Date Filing Date
HU842819A HU198091B (en) 1983-07-21 1984-07-20 Process for producing ganglioside derivatives and pharmaceutical compositions comprising same as active ingedient

Country Status (9)

Country Link
US (2) US4728641A (hu)
EP (1) EP0136438B1 (hu)
JP (1) JPS6084296A (hu)
AT (1) ATE75480T1 (hu)
DE (1) DE3485680D1 (hu)
DK (1) DK166828B1 (hu)
ES (1) ES534494A0 (hu)
HU (1) HU198091B (hu)
IT (1) IT1168205B (hu)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH660557A5 (fr) * 1984-10-26 1987-05-15 Nestle Sa Composition anti-bacterienne et procede de preparation de ses constituants actifs.
DK17885D0 (da) * 1985-01-14 1985-01-14 Karlsson Karl Anders Antiviralt middel
JPH0653764B2 (ja) * 1985-07-31 1994-07-20 三井東圧化学株式会社 モノシアロガングリオシドの製造法
ATE94395T1 (de) * 1986-05-09 1993-10-15 Pulverer Gerhard Verwendung von spezifischen monosacchariden zur herstellung eines arzneimittels zur verhinderung von metastasen maligner tumore.
IT1208751B (it) * 1986-06-30 1989-07-10 Fidia Farmaceutici Possibile uso dei gangliosidi esogeni in malattie tumorali come fattore protettivo contro la neurotossicita' da farmaci antitumorali
EP0255717A3 (en) * 1986-08-06 1990-12-05 Mect Corporation Ganglioside related compounds and method of producing the same
IT1212041B (it) * 1987-11-02 1989-11-08 Fidia Farmaceutici Gangliosidi esteri interni come agenti terapeutici capaci di eliminare il dolore nelle neuropatie periferiche
WO1991008748A1 (en) * 1989-12-13 1991-06-27 Glycomed Incorporated Synthesis of rotavirus receptor saccharides
AU6902691A (en) * 1989-12-13 1991-07-18 Glycomed Incorporated Synthetic receptor molecules recognizable by a rotavirus
WO1993002686A1 (en) * 1991-07-31 1993-02-18 The Regents Of The University Of California Gangliosides with immunosuppressive ceramide moieties
US5936076A (en) * 1991-08-29 1999-08-10 Kirin Beer Kabushiki Kaisha αgalactosylceramide derivatives
DE4204907A1 (de) * 1992-02-14 1993-08-19 Reutter Werner Neuartige glykokonjugate mit n-substituierten neuraminsaeuren als mittel zur stimulierung des immunsystems
TW261533B (hu) * 1992-07-16 1995-11-01 Kirin Brewery
KR100281264B1 (ko) * 1992-10-22 2001-02-01 마나배 게이사꾸 신규한 스핀고당 지질 및 그의 사용
EP0694558B1 (en) * 1993-04-15 1999-01-27 Kirin Beer Kabushiki Kaisha Novel sphingoglycolipid and use thereof
DE19602108A1 (de) * 1996-01-22 1997-07-24 Beiersdorf Ag Gegen Bakterien, Parasiten, Protozoen, Mycota und Viren wirksame Substanzen
US5747476A (en) * 1996-07-17 1998-05-05 Mortar & Pestle Veterinary Pharmacy, Inc. Treatment of equine protozoal myeloencephalitis
DE19643585A1 (de) * 1996-10-22 1998-04-23 Beiersdorf Ag Antiadhäsive Sphingolipide
AU2001285359A1 (en) * 2000-09-01 2002-03-13 Neuronyx, Inc. Novel synthetic gangliosides
WO2002018402A2 (en) * 2000-09-01 2002-03-07 Neuronyx, Inc. Novel synthetic gangliosides
US9969980B2 (en) * 2001-09-21 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
EP1358910A1 (de) * 2002-05-02 2003-11-05 B.R.A.H.M.S Aktiengesellschaft Verfahren und Mittel zur Prävention, Hemmung und Therapie von Krebserkrankungen
EP1367395A1 (de) * 2002-05-02 2003-12-03 B.R.A.H.M.S Aktiengesellschaft Diagnose von Neoplasmen mit Hilfe von anti-Gangliosid-Antikörpern
US9969977B2 (en) * 2002-09-20 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
NZ542148A (en) 2003-03-06 2008-05-30 Neose Technologies Inc Methods and compositions for the enzymatic synthesis of gangliosides
JP4965063B2 (ja) * 2004-05-07 2012-07-04 雪印メグミルク株式会社 口腔内細菌叢改善剤、抗菌剤及び生育促進剤。
US9599358B2 (en) 2004-09-23 2017-03-21 Csr Building Products Limited Hybrid ventilator
EA201070022A1 (ru) * 2007-06-15 2010-06-30 Гарнет Байотерапьютикс Инк. Лечение заболеваний и нарушений с использованием самообновляющихся образующих колонии клеток, культивированных и размноженных in vitro
US20090239834A1 (en) * 2008-03-21 2009-09-24 Braincells, Inc. Mcc-257 modulation of neurogenesis
DE102010024041A1 (de) * 2010-05-16 2013-04-04 Alfred Kroll Symtomfreiheit der Atemwege

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT295036B (de) * 1968-11-29 1971-12-27 Leikola Erkki E Verfahren zur Herstellung von neuen Produkten tierischen Ursprungs
US4125492A (en) * 1974-05-31 1978-11-14 Pedro Cuatrecasas Affinity chromatography of vibrio cholerae enterotoxin-ganglioside polysaccharide and the biological effects of ganglioside-containing soluble polymers
FR2478104B1 (fr) * 1980-03-17 1986-08-08 Merieux Inst Nouveaux derives de gangliosides, leur preparation et leur application
US4464360A (en) * 1980-05-09 1984-08-07 Hakon Leffler Glycosphingalipids for inhibiting bacterial adherence
CH658458A5 (fr) * 1981-12-17 1986-11-14 Lucchini Lab Sa Procede pour l'obtention du lacto-n-norhexaosyl ceramide.

Also Published As

Publication number Publication date
ATE75480T1 (de) 1992-05-15
EP0136438B1 (en) 1992-04-29
US4728641A (en) 1988-03-01
DK166828B1 (da) 1993-07-19
HU198091B (en) 1989-07-28
US4831021A (en) 1989-05-16
IT1168205B (it) 1987-05-20
EP0136438A3 (en) 1987-05-13
DK356984D0 (da) 1984-07-20
ES8603191A1 (es) 1985-12-01
DE3485680D1 (de) 1992-06-04
IT8348724A0 (it) 1983-07-21
DK356984A (da) 1985-01-22
ES534494A0 (es) 1985-12-01
JPS6084296A (ja) 1985-05-13
EP0136438A2 (en) 1985-04-10

Similar Documents

Publication Publication Date Title
HUT35690A (en) Process for preparing ganglioside derivatives and pharmaceutical compositions containing such compounds as active substances
AU549885B2 (en) Heparin degradation via ascorbic acid, cupric acetate and hydrogen peroxide
GB1393503A (en) Aminoadamantanes and their use as medicaments for affecting the central nervous system
IE36724B1 (en) Imidazole derivatives
HUT38263A (en) Process for rendering active substances soluble and production of therapeutic compositions comprising these substances
IE37913L (en) p-TOLUENESULPHONIC ACID SALT OF S-ADENOSYL-L-METHIONINE
JPH08500589A (ja) アストラガルス ポリサッカライド免疫調節剤
DE2146400C3 (de) Neuer biosynthetischer Wirkstoff, Verfahren zu seiner Herstellung und diesen Wirkstoff enthaltende Arzneimittelpräparate
AU587054B2 (en) Novel pharmaceutical compositions intended to the treatment of neuropathies and insuring the nervous regeneration
NO923581L (no) Sykliske substituerte imidazolylpropensyrederivater
JPS5748957A (en) Novel antibiotic bmg 162-af2, its preparation and carcinostatic agent comprising it as active ingredient
AU545885B2 (en) Oral absorption of glycosidic antibiotics
MD679G2 (ro) Complecşi de incluziune a N-etoxicarbonil-3-morfolino-sidnoniminei sau sărurile lui cu ciclodextrinăsau cu derivaţii ei, prepararea acestora şi compoziţii farmaceutice care le conţin, procedeu de obţinere a lor şi procedeu de tratare
DE2803681C2 (hu)
US4327084A (en) Aqueous solution for intravenous administration
GB1438217A (en) 1-alkyl-5-nitro-imidaolyl-2-alkyl-pyridyl compounds and process for preparing them
Macrae et al. Observations on the liver filtrate factor of the vitamin B2 complex
DE2835878A1 (de) Oligosaccharid mit durch glucocorticoide bedingte enzyminduktion verstaerkender wirkung, verfahren zu seiner herstellung und diese verbindung enthaltende arzneimittel
CN110882263B (zh) 礁膜寡二糖在制备抗乳腺癌药物中的应用
ES8800198A1 (es) Procedimiento para preparar derivados de acidos aziridin-2- carboxilicos substituidos en n
CN109828075B (zh) 一种辣木叶中印度辣木素和凤尾辣木素的鉴别方法
RU2001628C1 (ru) Способ стерилизации лидазы
JPS572297A (en) Moranoline derivative and its preparation
GB856413A (en) New lipo-polysaccharides of bacterial origin and process for prearing same
SU1176477A1 (ru) Способ получения аммифурина

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee